Bioline Rx | BLRX - Operating Expenses

Stock Price
2.27
Daily Change
-0.03 -1.30%
Monthly
-4.62%
Yearly
-29.50%
Q2 Forecast
2.20

Bioline Rx reported $2.63M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Arca Biopharma USD 34.43M 326K Dec/2025
Bio Path USD 488K 4.07M Sep/2025
Bioline Rx USD 2.63M 24K Sep/2025
Capricor Therapeutics USD 29.16M 2.87M Dec/2025